Company Profile
Ventana Medical Systems, Inc.
Company Overview
At Roche, 85,000 people across 150 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. Our integrated staining, workflow management and digital pathology solutions optimize laboratory efficiency to reduce errors and support diagnosis for pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and companion diagnostics.
Company History
Ventana Medical Systems, Inc., was founded in 1985 by a professor and practicing pathologist, Dr. Thomas Grogan. In the mid 1980s, Grogan and a small team of highly skilled and dedicated doctors, scientists, and engineers pioneered the automation and standardization of tissue biopsy testing. The team pursued a shared vision to deliver test results to patients faster, but it didn’t end there. Knowing that tissue contains a wealth of information that is vital beyond diagnosis, they expanded their mission to research the chemistry of cancer biopsies. Tissue-based assays have enabled physicians to personalize diagnosis and treatment options for individual cancer patients.
Today, this patient-centered approach and spirit of innovation continues to drive Ventana forward. It inspires us to continuously innovate pathology by improving laboratory efficiency and by generating new assays to address unmet medical needs. Through the use of automation, laboratory turnaround times have decreased from several weeks to a few days. Patients and their physicians spend less time waiting for results, and more time fighting the disease.
Further inspired by the sequencing of the human genome, Ventana has pioneered collaborations with cancer researchers, technology innovators, and drug makers, to enable the discovery of new targets for cancer therapeutics, and the development of new tests that can identify patients who will most likely benefit from these therapies. Known as Personalized Healthcare, this discipline is the sole focus for Translational Diagnostics — a Ventana team that collaborates with pharmaceutical companies to develop companion diagnostics for cancer therapeutics.
Ventana has grown to be the world’s leading developer and manufacturer of tissue-based diagnostic instruments and tests focused on the detection of cancer. Ventana employees continue to pursue the same deeply rooted vision of innovating diagnostic testing to improve the lives of all patients afflicted with cancer worldwide.
Benefits
As one of the top companies to work for in the United States, Roche offers employees one of the most comprehensive benefits programs in the industry.
A number of programs reflect Roche’s ' unique workplace and provide employees with opportunities to celebrate the culture, learn more about the company, support the community, continue their education, and achieve their personal and professional goals.
Roche also offers a wide variety of benefits, services and programs designed to make it easier and more convenient for employees to manage the sometimes difficult task of juggling work and everyday life.
At Roche people drive our business and are a top priority. Because we realize each person has different personal requirements, we strive to provide a complete benefits package that is competitive and, more importantly, meets the diverse needs of our people and their families.